Seeking Alpha

Stryker (SYK) signs a definitive agreement to acquire orthobiologic and biosurgery product maker...

Stryker (SYK) signs a definitive agreement to acquire orthobiologic and biosurgery product maker Orthovita (VITA) for ~$304M in cash. Shareholders will receive $3.85/share, a 41% premium over Friday's close. The deal also includes $12M in debt. VITA +40.3% premarket. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|